Maravai LifeSciences Holdings, Inc. MRVI TriLink — Cost of revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — cost of revenue of $20.7M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue decreased by 16.6% year-over-year, from $24.82M to $20.7M.
- What does trilink — cost of revenue mean?
- This represents the direct costs attributable to the production of goods and services sold by the segment, including raw materials, labor, and manufacturing overhead. It is a fundamental measure of the segment's gross margin efficiency and production cost control.